30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Lifecore Biomedical Inc (LFCR)

Track

Stock chart
Ticker: LFCR Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
English Aron R.
1 sale — total 1,071,555 USD
Sale 28 May 2025
Value US$980,715.01 | Price 167.74 | Shares 17,854
Sale 27 May 2025
Value US$692,445.24 | Price 72.32 | Shares 56,144
Sale 23 May 2025
Value US$649,386.21 | Price 6.75 | Shares 96,137
Sale 13 May 2025
Value US$86,352.80 | Price 7.00 | Shares 12,334
Sale 12 May 2025
Value US$321,426.02 | Price 7.03 | Shares 45,698
Sale 9 May 2025
Value US$4,900.00 | Price 7.00 | Shares 700
Sale 8 May 2025
Value US$35,693.14 | Price 7.00 | Shares 5,098
Sale 7 May 2025
Value US$111,098.56 | Price 7.01 | Shares 15,847
Sale 6 May 2025
Value US$4,940.09 | Price 7.05 | Shares 701
Sale 5 May 2025
Value US$173,830.71 | Price 7.08 | Shares 24,543
Buy 8 Jan 2025
Value US$97,580.00 | Price 5.74 | Shares 17,000
Proposed sale 20 Nov 2024
Value US$71,691.00 | Price 7.17 | Shares 10,000
Proposed sale 11 Nov 2024
Value US$205,803.23 | Price 6.64 | Shares 30,990
Proposed sale 31 Oct 2024
Value US$232,888.31 | Price 5.68 | Shares 40,989
Proposed sale 7 Oct 2024
Value US$65,482.00 | Price 5.19 | Shares 12,617
Buy 3 Oct 2024
Value US$695,987.30 | Price 4.10 | Shares 169,753
Buy 3 Oct 2024
Value US$504,013.00 | Price 4.10 | Shares 122,930
Buy 3 Oct 2024
Value US$623,618.20 | Price 4.10 | Shares 152,102
Buy 3 Oct 2024
Value US$5,376,379.20 | Price 4.10 | Shares 1,311,312
Proposed sale 20 Sep 2024
Value US$82,350.00 | Price 5.49 | Shares 15,000
Buy 25 Nov 2022
Value US$2,251,413.42 | Price 7.97 | Shares 282,486
Buy 25 Nov 2022
Value US$2,751,722.20 | Price 7.97 | Shares 345,260
Buy 25 Nov 2022
Value US$2,251,413.42 | Price 7.97 | Shares 282,486
Buy 25 Nov 2022
Value US$2,751,722.20 | Price 7.97 | Shares 345,260
Buy 24 Oct 2022
Value US$1,189,230.00 | Price 8.09 | Shares 147,000
Buy 24 Oct 2022
Value US$833,270.00 | Price 8.09 | Shares 103,000
Buy 13 Jan 2022
Value US$237,690.00 | Price 10.43 | Shares 22,800
Buy 13 Jan 2022
Value US$152,205.00 | Price 10.43 | Shares 14,600
Buy 13 Jan 2022
Value US$317,144.40 | Price 10.41 | Shares 30,480
Buy 13 Jan 2022
Value US$203,105.60 | Price 10.41 | Shares 19,520
Buy 12 Jan 2022
Value US$2,184,137.90 | Price 10.41 | Shares 209,872
Buy 12 Jan 2022
Value US$937,962.10 | Price 10.41 | Shares 90,128
Buy 12 Jan 2022
Value US$20,820.00 | Price 10.41 | Shares 2,000
Buy 12 Jan 2022
Value US$83,120.00 | Price 10.39 | Shares 8,000
Buy 20 Apr 2021
Value US$112,600.00 | Price 11.26 | Shares 10,000
Buy 19 Apr 2021
Value US$22,100.00 | Price 11.05 | Shares 2,000
Buy 15 Apr 2021
Value US$21,960.00 | Price 10.98 | Shares 2,000
Buy 14 Apr 2021
Value US$106,200.00 | Price 10.62 | Shares 10,000
Buy 14 Apr 2021
Value US$95,490.00 | Price 10.61 | Shares 9,000
Buy 13 Apr 2021
Value US$20,360.00 | Price 10.18 | Shares 2,000
Buy 12 Apr 2021
Value US$50,399.55 | Price 9.99 | Shares 5,045
Buy 11 Feb 2021
Value US$16,632.00 | Price 11.88 | Shares 1,400
Buy 10 Feb 2021
Value US$23,280.00 | Price 11.64 | Shares 2,000
Buy 9 Feb 2021
Value US$24,120.00 | Price 12.06 | Shares 2,000
Buy 8 Feb 2021
Value US$21,940.00 | Price 10.97 | Shares 2,000
Buy 5 Feb 2021
Value US$21,740.00 | Price 10.87 | Shares 2,000
Buy 19 Jan 2021
Value US$109,800.00 | Price 10.98 | Shares 10,000
Buy 12 Jan 2021
Value US$146,064.00 | Price 10.74 | Shares 13,600
Buy 11 Jan 2021
Value US$69,184.00 | Price 10.81 | Shares 6,400
Buy 14 Oct 2020
Value US$89,144.16 | Price 10.32 | Shares 8,638
Buy 13 Oct 2020
Value US$13,878.78 | Price 10.19 | Shares 1,362
Buy 11 May 2020
Value US$54,000.00 | Price 10.80 | Shares 5,000
Buy 6 Nov 2019
Value US$9,273.50 | Price 10.91 | Shares 850
Buy 5 Nov 2019
Value US$40,622.00 | Price 10.69 | Shares 3,800
Buy 5 Nov 2019
Value US$103,800.00 | Price 10.38 | Shares 10,000
Buy 31 Oct 2019
Value US$49,674.00 | Price 9.74 | Shares 5,100
Buy 14 Oct 2019
Value US$46,600.00 | Price 9.32 | Shares 5,000
Buy 10 Oct 2019
Value US$48,350.00 | Price 9.67 | Shares 5,000
Buy 8 Oct 2019
Value US$99,600.00 | Price 9.96 | Shares 10,000
Buy 7 Oct 2019
Value US$81,120.00 | Price 10.14 | Shares 8,000
Buy 4 Oct 2019
Value US$72,800.00 | Price 10.40 | Shares 7,000
Buy 5 Aug 2019
Value US$105,000.00 | Price 10.50 | Shares 10,000
Buy 2 Aug 2019
Value US$214,400.00 | Price 10.72 | Shares 20,000
Buy 10 Apr 2019
Value US$309,900.00 | Price 10.33 | Shares 30,000
Buy 9 Apr 2019
Value US$102,400.00 | Price 10.24 | Shares 10,000
Buy 8 Apr 2019
Value US$207,600.00 | Price 10.38 | Shares 20,000
Buy 8 Feb 2019
Value US$60,750.00 | Price 12.15 | Shares 5,000
Buy 7 Feb 2019
Value US$95,590.00 | Price 12.10 | Shares 7,900
Buy 6 Feb 2019
Value US$247,600.00 | Price 12.38 | Shares 20,000
Buy 11 Jan 2019
Value US$6,100.50 | Price 11.62 | Shares 525
Buy 10 Jan 2019
Value US$226,600.00 | Price 11.33 | Shares 20,000
Buy 10 Jan 2019
Value US$11,230.00 | Price 11.23 | Shares 1,000
Buy 8 Jan 2019
Value US$51,030.00 | Price 11.34 | Shares 4,500
Buy 8 Jan 2019
Value US$224,800.00 | Price 11.24 | Shares 20,000
Buy 8 Jan 2019
Value US$281,250.00 | Price 11.25 | Shares 25,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-28 2025-05-28 S Sale
3.7
English Aron R.
Large shareholder
17,854 +0.8%
167.74
US$980,715 		17,854 +0.8% 167.74 US$980,715
2025-05-28 2025-05-27 S Sale
3.7
English Aron R.
Large shareholder
56,144 -26.6%
72.32
US$692,445 		56,144 -26.6% 72.32 US$692,445
2025-05-28 2025-05-23 S Sale
3.7
English Aron R.
Large shareholder
22,146 +19.5%
206.64
US$4,269,759 		22,146 +19.5% 206.64 US$4,269,759
2025-05-16 2025-05-13 S Sale
3.7
English Aron R.
Large shareholder
12,334 -0.7%
7.00
US$86,353 		12,334 -0.7% 7.00 US$86,353
2025-05-12 2025-05-12 S Sale
3.7
English Aron R.
Large shareholder
45,698 -2.7%
7.03
US$321,426 		45,698 -2.7% 7.03 US$321,426
2025-05-12 2025-05-09 S Sale
3.7
English Aron R.
Large shareholder
700 -0.0%
7.00
US$4,900 		700 -0.0% 7.00 US$4,900
2025-05-12 2025-05-08 S Sale
3.7
English Aron R.
Large shareholder
5,098 -0.3%
7.00
US$35,693 		5,098 -0.3% 7.00 US$35,693
2025-05-07 2025-05-07 S Sale
3.7
English Aron R.
Large shareholder
15,847 -0.9%
7.01
US$111,099 		15,847 -0.9% 7.01 US$111,099
2025-05-07 2025-05-06 S Sale
3.7
English Aron R.
Large shareholder
701 -0.0%
7.05
US$4,940 		701 -0.0% 7.05 US$4,940
2025-05-07 2025-05-05 S Sale
3.7
English Aron R.
Large shareholder
24,543 -1.4%
7.08
US$173,831 		24,543 -1.4% 7.08 US$173,831
2025-01-08 2025-01-08 B Purchase
2.3
Josephs Paul

Chief Executive Officer

Executive Director
17,000 +3.1%
5.74
US$97,580 		17,000 +3.1% 5.74 US$97,580
2024-11-20 2024-11-20 PrS Proposed sale
3.2
Morberg John D

Former officer

Officer
10,000
7.17
US$71,691 		10,000 7.17 US$71,691
2024-11-12 2024-11-11 PrS Proposed sale
3.2
Morberg John D

Former officer

Officer
30,990
6.64
US$205,803 		30,990 6.64 US$205,803
2024-10-31 2024-10-31 PrS Proposed sale
3.2
Morberg John D

Former officer

Officer
40,989
5.68
US$232,888 		40,989 5.68 US$232,888
2024-10-07 2024-10-07 PrS Proposed sale
3.2
Morberg John D

Former officer

Officer
12,617
5.19
US$65,482 		12,617 5.19 US$65,482
2024-10-07 2024-10-03 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
169,753 +7.0%
4.10
US$695,987 		169,753 +7.0% 4.10 US$695,987
2024-10-07 2024-10-03 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
122,930 +6.2%
4.10
US$504,013 		122,930 +6.2% 4.10 US$504,013
2024-10-07 2024-10-03 B Purchase
Kiper Christopher S
Non-Executive Director Large shareholder
152,102 +91.0%
4.10
US$623,618 		152,102 +91.0% 4.10 US$623,618
2024-10-07 2024-10-03 B Purchase
Kiper Christopher S
Non-Executive Director Large shareholder
1,311,312 +47.3%
4.10
US$5,376,379 		1,311,312 +47.3% 4.10 US$5,376,379
2024-09-20 2024-09-20 PrS Proposed sale
3.2
Morberg John D

Former officer

Officer
15,000
5.49
US$82,350 		15,000 5.49 US$82,350
2023-01-18 2022-11-25 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
282,486 +13.1%
7.97
US$2,251,413 		282,486 +13.1% 7.97 US$2,251,413
2023-01-18 2022-11-25 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
345,260 +21.2%
7.97
US$2,751,722 		345,260 +21.2% 7.97 US$2,751,722
2022-11-29 2022-11-25 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
282,486 +13.1%
7.97
US$2,251,413 		282,486 +13.1% 7.97 US$2,251,413
2022-11-29 2022-11-25 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
345,260 +21.2%
7.97
US$2,751,722 		345,260 +21.2% 7.97 US$2,751,722
2022-10-26 2022-10-24 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
147,000 +7.3%
8.09
US$1,189,230 		147,000 +7.3% 8.09 US$1,189,230
2022-10-26 2022-10-24 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
103,000 +6.8%
8.09
US$833,270 		103,000 +6.8% 8.09 US$833,270
2022-01-14 2022-01-13 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
22,800 +1.1%
10.43
US$237,690 		22,800 +1.1% 10.43 US$237,690
2022-01-14 2022-01-13 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
14,600 +1.0%
10.43
US$152,205 		14,600 +1.0% 10.43 US$152,205
2022-01-14 2022-01-13 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
30,480 +1.6%
10.41
US$317,144 		30,480 +1.6% 10.41 US$317,144
2022-01-14 2022-01-13 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
19,520 +1.3%
10.41
US$203,106 		19,520 +1.3% 10.41 US$203,106
2022-01-14 2022-01-12 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
209,872 +12.0%
10.41
US$2,184,138 		209,872 +12.0% 10.41 US$2,184,138
2022-01-14 2022-01-12 B Purchase
2.8
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
Large shareholder
90,128 +6.4%
10.41
US$937,962 		90,128 +6.4% 10.41 US$937,962
2022-01-14 2022-01-12 B Purchase
3.6
Schechter Joshua
Non-Executive Director
2,000 +inf%
10.41
US$20,820 		2,000 +inf% 10.41 US$20,820
2022-01-14 2022-01-12 B Purchase
3.6
Schechter Joshua
Non-Executive Director
8,000 +148.2%
10.39
US$83,120 		8,000 +148.2% 10.39 US$83,120
2021-04-22 2021-04-20 B Purchase
3.8
Walsh Patrick D
Non-Executive Director
10,000 +33.3%
11.26
US$112,600 		10,000 +33.3% 11.26 US$112,600
2021-04-20 2021-04-19 B Purchase
3.2
Morberg John D

Chief Financial Officer

Officer
2,000 +11.5%
11.05
US$22,100 		2,000 +11.5% 11.05 US$22,100
2021-04-16 2021-04-15 B Purchase
3.2
Morberg John D

Chief Financial Officer

Officer
2,000 +14.9%
10.98
US$21,960 		2,000 +14.9% 10.98 US$21,960
2021-04-15 2021-04-14 B Purchase
2.9
Hall James G

Vice President

Officer
10,000 +34.3%
10.62
US$106,200 		10,000 +34.3% 10.62 US$106,200
2021-04-15 2021-04-14 B Purchase
2.3
Bolles Albert D.

Chief Executive Officer

Officer
9,000 +24.9%
10.61
US$95,490 		9,000 +24.9% 10.61 US$95,490
2021-04-13 2021-04-13 B Purchase
3.2
Morberg John D

Chief Financial Officer

Officer
2,000 +21.3%
10.18
US$20,360 		2,000 +21.3% 10.18 US$20,360
2021-04-21 2021-04-12 B Purchase
3.6
Burgess Timothy P

Senior VP of Supply Chain

Officer
5,045 +98.9%
9.99
US$50,400 		5,045 +98.9% 9.99 US$50,400
2021-02-12 2021-02-11 B Purchase
3.2
Morberg John D

Chief Financial Officer

Officer
1,400 +17.5%
11.88
US$16,632 		1,400 +17.5% 11.88 US$16,632
2021-02-11 2021-02-10 B Purchase
3.2
Morberg John D

Chief Financial Officer

Officer
2,000 +33.3%
11.64
US$23,280 		2,000 +33.3% 11.64 US$23,280
2021-02-10 2021-02-09 B Purchase
3.2
Morberg John D

Chief Financial Officer

Officer
2,000 +50.0%
12.06
US$24,120 		2,000 +50.0% 12.06 US$24,120
2021-02-09 2021-02-08 B Purchase
3.2
Morberg John D

Chief Financial Officer

Officer
2,000 +100.0%
10.97
US$21,940 		2,000 +100.0% 10.97 US$21,940
2021-02-08 2021-02-05 B Purchase
3.2
Morberg John D

Chief Financial Officer

Officer
2,000 +inf%
10.87
US$21,740 		2,000 +inf% 10.87 US$21,740
2021-01-19 2021-01-19 B Purchase
2.3
Bolles Albert D.

Chief Executive Officer

Officer
10,000 +38.2%
10.98
US$109,800 		10,000 +38.2% 10.98 US$109,800
2021-01-13 2021-01-12 B Purchase
3.6
OBUS NELSON
Non-Executive Director
13,600 +0.5%
10.74
US$146,064 		13,600 +0.5% 10.74 US$146,064
2021-01-13 2021-01-11 B Purchase
3.6
OBUS NELSON
Non-Executive Director
6,400 +0.2%
10.81
US$69,184 		6,400 +0.2% 10.81 US$69,184
2020-10-15 2020-10-14 B Purchase
3.6
OBUS NELSON
Non-Executive Director
8,638 +0.3%
10.32
US$89,144 		8,638 +0.3% 10.32 US$89,144
2020-10-15 2020-10-13 B Purchase
3.6
OBUS NELSON
Non-Executive Director
1,362 +0.0%
10.19
US$13,879 		1,362 +0.0% 10.19 US$13,879
2020-05-12 2020-05-11 B Purchase
3.6
OBUS NELSON
Non-Executive Director
5,000 +0.2%
10.80
US$54,000 		5,000 +0.2% 10.80 US$54,000
2019-11-06 2019-11-06 B Purchase Bolles Albert D.

Chief Executive Officer

Officer
850 +3.4%
10.91
US$9,274 		850 +3.4% 10.91 US$9,274
2019-11-06 2019-11-05 B Purchase Bolles Albert D.

Chief Executive Officer

Officer
3,800 +17.7%
10.69
US$40,622 		3,800 +17.7% 10.69 US$40,622
2019-11-05 2019-11-05 B Purchase
3.6
OBUS NELSON
10,000 +0.3%
10.38
US$103,800 		10,000 +0.3% 10.38 US$103,800
2019-11-01 2019-10-31 B Purchase
3.6
Burgess Timothy P

Senior VP of Supply Chain
5,100 +inf%
9.74
US$49,674 		5,100 +inf% 9.74 US$49,674
2019-10-16 2019-10-14 B Purchase
3.6
OBUS NELSON
5,000 +0.2%
9.32
US$46,600 		5,000 +0.2% 9.32 US$46,600
2019-10-11 2019-10-10 B Purchase
3.6
OBUS NELSON
5,000 +0.2%
9.67
US$48,350 		5,000 +0.2% 9.67 US$48,350
2019-10-10 2019-10-08 B Purchase
3.6
OBUS NELSON
10,000 +0.4%
9.96
US$99,600 		10,000 +0.4% 9.96 US$99,600
2019-10-09 2019-10-07 B Purchase
3.6
OBUS NELSON
8,000 +0.3%
10.14
US$81,120 		8,000 +0.3% 10.14 US$81,120
2019-10-08 2019-10-04 B Purchase
3.6
OBUS NELSON
7,000 +0.2%
10.40
US$72,800 		7,000 +0.2% 10.40 US$72,800
2019-08-06 2019-08-05 B Purchase OBUS NELSON Non-Executive Director
10,000 +0.4%
10.50
US$105,000 		10,000 +0.4% 10.50 US$105,000
2019-08-05 2019-08-02 B Purchase OBUS NELSON Non-Executive Director
20,000 +0.7%
10.72
US$214,400 		20,000 +0.7% 10.72 US$214,400
2019-04-11 2019-04-10 B Purchase
3.6
OBUS NELSON
30,000 +1.1%
10.33
US$309,900 		30,000 +1.1% 10.33 US$309,900
2019-04-10 2019-04-09 B Purchase
3.6
OBUS NELSON
10,000 +0.4%
10.24
US$102,400 		10,000 +0.4% 10.24 US$102,400
2019-04-10 2019-04-08 B Purchase
3.6
OBUS NELSON
20,000 +0.7%
10.38
US$207,600 		20,000 +0.7% 10.38 US$207,600
2019-02-11 2019-02-08 B Purchase
3.6
OBUS NELSON
Non-Executive Director
5,000 +0.2%
12.15
US$60,750 		5,000 +0.2% 12.15 US$60,750
2019-02-11 2019-02-07 B Purchase
3.6
OBUS NELSON
Non-Executive Director
7,900 +0.3%
12.10
US$95,590 		7,900 +0.3% 12.10 US$95,590
2019-02-06 2019-02-06 B Purchase
3.6
OBUS NELSON
Non-Executive Director
20,000 +0.7%
12.38
US$247,600 		20,000 +0.7% 12.38 US$247,600
2019-01-14 2019-01-11 B Purchase
2.1
Powell Andrew Kenneth William
Non-Executive Director
525 +110.5%
11.62
US$6,100 		525 +110.5% 11.62 US$6,100
2019-01-14 2019-01-10 B Purchase
3.6
OBUS NELSON
Non-Executive Director
20,000 +0.7%
11.33
US$226,600 		20,000 +0.7% 11.33 US$226,600
2019-01-11 2019-01-10 B Purchase
3.2
Sohn Catherine A.
Non-Executive Director
1,000 +4.2%
11.23
US$11,230 		1,000 +4.2% 11.23 US$11,230
2019-06-03 2019-01-08 B Purchase
1.6
Carosella Deborah D
4,500 +52.8%
11.34
US$51,030 		4,500 +52.8% 11.34 US$51,030
2019-01-10 2019-01-08 B Purchase
1.6
GOLDBY STEVEN D
Non-Executive Director
20,000 +43.0%
11.24
US$224,800 		20,000 +43.0% 11.24 US$224,800
2019-01-09 2019-01-08 B Purchase
1.6
SKINNER GREGORY S

Chief Financial Officer

Officer
25,000 +9.5%
11.25
US$281,250 		25,000 +9.5% 11.25 US$281,250
Explore more

More insider trading research around Lifecore Biomedical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America